Project Grant K99GM160783
- Federal Grant Award Summary The National Institute of General Medical Sciences (NIGMS) awarded the University of California, San Diego a Project Grant totaling $784,799 under the Biomedical Research and Research Training program (CFDA 93.859) for the period of September 1, 2025, through August 31, 2030. This award supports fundamental research to characterize the genomic basis of rapid and repeated evolution in Aedes aegypti (yellow fever mosquito), using the species as a model system to...
- Federal Project Grant Award Summary The University of North Carolina at Chapel Hill received a $211,073 Project Grant from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855), awarded on April 20, 2026, with a completion date of March 31, 2028. This award funds the development of genomic resources to determine the genetic basis of insecticide resistance in sandfly vectors, specifically addressing Lutzomyia...
- Federal Grant Award Summary The National Institute of Allergy and Infectious Diseases (NIAID) awarded a $1,906,499 Project Grant to the University of North Carolina at Chapel Hill on September 25, 2025, under the Allergy and Infectious Diseases Research program (CFDA 93.855) to develop deep learning surrogates for predicting the spread of antimalarial drug resistance. The project, extending through August 31, 2030, addresses the critical public health threat posed by artemisinin partial...
- Federal Grant Award Summary The University of North Carolina at Chapel Hill received a $470,963 Project Grant from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859), with performance extending from May 1, 2026, through April 30, 2031. This award funds research focused on enhanced sampling and computational characterization of intracellular protein interactions between G-protein-coupled receptors (GPCRs) and...
- Federal Grant Award Summary The University of North Carolina at Chapel Hill received a $229,360 Project Grant (R21) from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855), awarded April 15, 2026, with a completion date of March 31, 2028. This exploratory research award supports investigator-initiated biomedical research to identify and validate causal genetic variants that regulate chikungunya virus...
- Federal Grant Award Summary The University of North Carolina at Charlotte received a $174,544 Project Grant from the National Science Foundation's Division of Information and Intelligent Systems (CFDA 47.070: Computer and Information Science and Engineering) effective July 1, 2025 through June 30, 2027. This Computer Research Infrastructure (CRII) award supports the development of a deep learning-enhanced geospatial modeling framework designed to identify human-vector contact zones (HVCZ) that...
- Federal Grant Award Summary The University of Chicago received a $451,000 Project Grant from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859), effective April 1, 2026, through January 31, 2031. This award funds fundamental research investigating how human population demography, genetic structure, and natural selection shape the genetic architecture of human traits. The research will develop novel genomic...
- Federal Project Grant Award Summary The University of Pittsburgh received a $417,620 Project Grant from the National Institute of General Medical Sciences under the Biomedical Research and Research Training program (CFDA 93.859), awarded March 1, 2026, with completion targeted for December 31, 2030. This award supports computational research developing statistical methods to quantify natural selection and predict evolutionary dynamics from temporal genetic data—sequences and phenotypes sampled...
- Federal Grant Award Summary The University of North Carolina at Chapel Hill received a $432,135 Project Grant from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859) effective May 15, 2026, with a completion date of January 31, 2031. This award supports fundamental research investigating the molecular mechanisms of myosin-X (MYO10) and filopodial function, with the primary deliverable being scientific knowledge and...
- Federal Grant Award Summary The University of California, San Diego received a Project Grant award of $376,498 from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859), effective August 1, 2025, with a completion date of July 31, 2030. The award funds research into active genetic systems—CRISPR-based genetic technologies that bypass traditional inheritance patterns to enable self-propagating genetic elements known...
The University of North Carolina at Chapel Hill received a $113,464 Project Grant from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859), with performance from May 1, 2026, through April 30, 2028. The project develops novel computational methods for detecting positive selection in mosquitoes, addressing critical limitations in current machine learning approaches to evolutionary biology. The research delivers three key products: (1) a new method capable of detecting and distinguishing between multiple modes of natural selection while accounting for model mis-specification, applied to yellow fever mosquito populations to elucidate genomic mechanisms of insecticide resistance; (2) analysis of structural variation (genomic variations greater than 50 base pairs) using long-read sequencing data to understand its role in rapid adaptation; and (3) the first machine learning tool designed to detect adaptive tracking, an understudied form of rapid adaptation resulting from fluctuating selective pressures. This research directly supports NIGMS's mission to advance fundamental understanding of biological processes through investigator-initiated basic research. The methodological innovations address significant gaps in population genetics by improving the accuracy of detecting genomic signatures of rapid adaptation, with direct applicability to understanding insecticide resistance mechanisms in disease vectors—findings with potential public health implications for vector-borne disease control strategies.Federal Grant Award Summary
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $113.5k | 4/27/26 |